Accutar Biotechnology
PrivateLast Round
Series C
Apr 7, 2021
Total Funding Raised
$63.15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Accutar Biotechnology is a clinical-stage biotechnology company that utilizes an artificial intelligence-empowered platform for drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accutar Biotechnology Comparables
Compare Accutar Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SEED Therapeutics | 84% | |
| Celeris Therapeutics | 84% | |
| Genesis Molecular AI | 84% | |
Accutar Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 7, 2021 | ||||
| Early Funding | Dec 21, 2020 | ||||
| Series B | Dec 21, 2020 | ||||
| Early Funding | Aug 12, 2019 | ||||
| Series A | Jan 10, 2018 | ||||
Series A | Dec 5, 2017 |
Accutar Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDH Investments | Early Funding, Series C, Series B |
| IDG Capital | Series C, Series A |
| ZhenFund | Seed |
| Primavera Capital Group | Early Funding, Series C |
| Primavera Venture Partners | Series B |
| Yunfeng Capital | Series C |
| CDH Investments | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 299% MoM, reaching 1.1K.
- Dec 5, 2017
Raised Series A led by IDG Capital.
Accutar Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Accutar Biotechnology's valuation, stock price, and market status.